losartan has been researched along with D-fructopyranose in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Cachofeiro, V; Lahera, V; Maeso, R; Navarro-Cid, J; Perez-Vizcaino, F; Ruilope, LM; Tamargo, J | 1 |
| Iyer, SN; Katovich, MJ | 2 |
| Castro, C; Cruzado, M; González, S; Miatello, R; Risler, N; Zumino, AP | 1 |
| Hsieh, PS | 1 |
| Carranza, A; Mayer, MA; Peredo, HA; Puyó, AM | 1 |
| Brosnihan, KB; Elased, KM; Irigoyen, MC; Key, M; Morris, M; Senador, D | 1 |
| Bravo, G; del-Rio-Navarro, BE; Hong, E; Huang, F; Lezama, MA; Ontiveros, JA; Villafaña, S | 1 |
| Guo, Q; Hu, C; Ito, S; Jiang, Y; Mori, T; Nakamichi, T; Ogawa, S; Ohsaki, Y; Sato, H; Yoneki, Y | 1 |
| Prior, SJ | 1 |
| Abdulla, MH; Abdullah, NA; Johns, EJ; Sattar, MA | 2 |
| Hong, E; Moreno, JA | 1 |
| Beau-Salinas, F; Bejan-Angoulvant, T; Jonville-Béra, AP; Lengellé, C | 1 |
| Ahn, YM; Cha, JD; Choi, KM; Kang, DG; Kho, MC; Kim, HY; Lee, HS; Lee, YJ; Park, JH; Park, MC; Tan, R; Yoon, JJ | 1 |
| Majer, J; Masajtis-Zagajewska, A; Nowicki, M | 1 |
1 trial(s) available for losartan and D-fructopyranose
| Article | Year |
|---|---|
Losartan and Eprosartan Induce a Similar Effect on the Acute Rise in Serum Uric Acid Concentration after an Oral Fructose Load in Patients with Metabolic Syndrome.
Topics: Acrylates; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Fructose; Humans; Hypertension; Imidazoles; Losartan; Metabolic Syndrome; Middle Aged; Thiophenes; Uric Acid | 2021 |
15 other study(ies) available for losartan and D-fructopyranose
| Article | Year |
|---|---|
Effects of losartan on blood pressure, metabolic alterations, and vascular reactivity in the fructose-induced hypertensive rat.
Topics: Analysis of Variance; Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Glucose; Blood Pressure; Endothelins; Fructose; Hypertension; Imidazoles; In Vitro Techniques; Insulin; Insulin Resistance; Losartan; Male; Mesenteric Artery, Superior; Rats; Rats, Sprague-Dawley; Tetrazoles; Triglycerides; Vasoconstriction | 1995 |
Effect of chronic losartan potassium treatment on fructose-induced hypertension.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Dietary Carbohydrates; Fructose; Hypertension; Imidazoles; Losartan; Male; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Tetrazoles | 1994 |
Effect of acute and chronic losartan treatment on glucose tolerance and insulin sensitivity in fructose-fed rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Body Weight; Cardiomegaly; Diet; Fructose; Glucose Tolerance Test; Hyperinsulinism; Imidazoles; Insulin; Insulin Resistance; Losartan; Male; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Tetrazoles | 1996 |
Chronic administration of losartan reverses cardiovascular changes in hypertensive fructose-fed rats.
Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Antihypertensive Agents; Endothelium; Fructose; Hypertension; Losartan; Male; Microvascular Angina; Nitric Oxide; Nitric Oxide Synthase; Rats; Receptor, Angiotensin, Type 2 | 2003 |
Reversal of fructose-induced hypertension and insulin resistance by chronic losartan treatment is independent of AT2 receptor activation in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Antihypertensive Agents; Fructose; Glucose; Glucose Clamp Technique; Hypertension; Imidazoles; Insulin Resistance; Liver; Losartan; Male; Oligopeptides; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2 | 2005 |
Pioglitazone and losartan modify hemodynamic and metabolic parameters and vascular prostanoids in fructose-overloaded rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Blood Pressure; Blood Vessels; Dinoprostone; Drug Synergism; Epoprostenol; Fructose; Hemodynamics; In Vitro Techniques; Losartan; Male; Mesentery; Pioglitazone; PPAR gamma; Prostaglandins; Rats; Rats, Sprague-Dawley; Thiazolidinediones; Thromboxanes; Triglycerides | 2008 |
Cardiovascular interactions between losartan and fructose in mice.
Topics: Analysis of Variance; Animals; Antihypertensive Agents; Blood Pressure; Blotting, Western; Cardiovascular Physiological Phenomena; Cholesterol; Disease Models, Animal; Drug Interactions; Fructose; Heart Rate; Insulin; Kidney; Losartan; Male; Mice; Mice, Inbred C57BL; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1 | 2010 |
Effect of losartan on vascular function in fructose-fed rats: the role of perivascular adipose tissue.
Topics: Acetylcholine; Adipose Tissue; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Thoracic; Disease Models, Animal; Fructose; Hypertension; Losartan; Male; Metabolic Syndrome; Norepinephrine; Rats; Rats, Wistar; Vasoconstriction; Vasodilation | 2010 |
Losartan modulates muscular capillary density and reverses thiazide diuretic-exacerbated insulin resistance in fructose-fed rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Capillaries; Fructose; Glucose Clamp Technique; Hydrochlorothiazide; Insulin Resistance; Losartan; Male; Muscle, Skeletal; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System | 2012 |
Anti-hypertensive therapy and insulin sensitivity: regulation through the microcirculation?
Topics: Animals; Capillaries; Fructose; Hydrochlorothiazide; Insulin Resistance; Losartan; Male; Muscle, Skeletal | 2012 |
The effect of losartan and carvedilol on renal haemodynamics and altered metabolism in fructose-fed Sprague-Dawley rats.
Topics: Angiotensin II; Animals; Body Weight; Carbazoles; Carvedilol; Fructose; Glucose Tolerance Test; Hemodynamics; Insulin Resistance; Kidney; Losartan; Male; Norepinephrine; Phenylephrine; Propanolamines; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents | 2012 |
A single oral dose of fructose induces some features of metabolic syndrome in rats: role of oxidative stress.
Topics: Administration, Oral; Animals; Blood Glucose; Blood Pressure; Dose-Response Relationship, Drug; Fructose; Glutathione; Hyperglycemia; Hyperuricemia; Insulin; Insulin Resistance; Liver; Losartan; Male; Metabolic Syndrome; Methyldopa; Oxidative Stress; Rats; Rats, Wistar; Streptozocin; Thioctic Acid; Uric Acid | 2013 |
The effect of high-fructose intake on the vasopressor response to angiotensin II and adrenergic agonists in Sprague-Dawley rats.
Topics: Angiotensin II; Animals; Fructose; Hemodynamics; Losartan; Male; Methoxamine; Norepinephrine; Phenylephrine; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2 | 2013 |
[Drugs news].
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Anti-Obesity Agents; Anticonvulsants; Aorta; Aortic Aneurysm; Atenolol; Cleft Palate; Female; Fructose; Hemangioma; Humans; Losartan; Male; Marfan Syndrome; Pregnancy; Prenatal Exposure Delayed Effects; Skin Neoplasms | 2015 |
Fermented Red Ginseng Potentiates Improvement of Metabolic Dysfunction in Metabolic Syndrome Rat Models.
Topics: Adipocytes; Alanine Transaminase; Animals; Aspartate Aminotransferases; Blood Glucose; Blood Pressure; Body Weight; Cholesterol, HDL; Cholesterol, LDL; Disease Models, Animal; Down-Regulation; Endothelin-1; Fermentation; Fructose; Glucose Transporter Type 4; Insulin Receptor Substrate Proteins; Liver; Losartan; Metabolic Syndrome; Obesity; Organ Size; Panax; Phytotherapy; Plant Preparations; Rats; Triglycerides; Up-Regulation | 2016 |